India Bioanalytical Testing Service Market

India Bioanalytical Testing Service Market Overview:

The India bioanalytical testing service market size reached USD 111.13 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 232.35 Million by 2033, exhibiting a growth rate (CAGR) of 8.50% during 2025-2033. The market is witnessing significant growth, driven by the rising demand for bioanalytical testing in biopharmaceutical development and the widespread adoption of digital and automated bioanalytical testing technologies.

India Bioanalytical Testing Service Market Trends:

Rising Demand for Bioanalytical Testing in Biopharmaceutical Development

The bioanalytical testing service market in India is experiencing significant growth due to the expanding biopharmaceutical sector. With increasing research and development (R&D) activities in biologics, biosimilars, and gene therapies, pharmaceutical companies are seeking advanced bioanalytical testing solutions to ensure regulatory compliance and product efficacy. For instance, as per industry reports, India’s biologics and biosimilars market grew from $6 billion in 2022 to a projected $12 billion by 2025. As these tests are greatly helpful in the drug development and approval processes, the demand for PK, PD, and immunogenicity testing has increased. These CROs and bioanalytical laboratories in India are furthering their stands by applying the latest technologies like LC-MS/MS and ligand-binding assays. The other reason for global pharma companies sending bioanalytical testing work to India is the cost advantage, coupled with the availability of a skilled labor pool. The market is further boosted by government initiatives like "Make in India" and increased growth of the biotechnology sector. Regulatory bodies like CDSCO and DCGI are modifying their guidance to match the international standard. This is establishing India as a preferred site for bioanalytical testing along with the increasing partnerships with local laboratories and multinational companies.

Growing Adoption of Digital and Automated Bioanalytical Testing Technologies

The India bioanalytical testing service market is witnessing a transformation with the growing adoption of digital and automated technologies. Laboratories are increasingly integrating automation, artificial intelligence (AI), and cloud-based data management systems to enhance efficiency, accuracy, and compliance with regulatory standards. These advancements reduce manual errors, improve turnaround times, and facilitate large-scale data analysis for better decision-making in drug development. Automation in bioanalytical testing is streamlining processes, such as sample preparation, high-throughput screening, and bioassay development. Liquid handling robots, AI-driven image analysis, and automated data processing are improving the precision of bioanalytical workflows. Additionally, cloud-based Laboratory Information Management Systems (LIMS) are enabling real-time data access, secure storage, and seamless collaboration between research teams and regulatory bodies. For instance, in 2024, the Indian government entered into a collaboration with LabVantage Solutions to implement LIMS in 50 hospitals and research centers, integrating AI and ML for automation, predictive analytics, and improved laboratory data management. The widespread adoption of digital tools is also enhancing compliance with Good Laboratory Practice (GLP) and Good Clinical Practice (GCP) guidelines. With increasing regulatory scrutiny and the need for data integrity in bioanalytical testing, Indian laboratories are investing in AI-driven validation and compliance tracking systems. As the industry shifts towards digitization and automation, the efficiency and scalability of bioanalytical testing services in India are expected to improve, strengthening the country’s position as a global bioanalytical testing hub.

India Bioanalytical Testing Service Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the region level for 2025-2033. Our report has categorized the market based on molecular type, test type, and workflow.

Molecular Type Insights:

• Small Molecule
• Large Molecule
  • LC-MS Studies
  • Immunoassays
  • Others

The report has provided a detailed breakup and analysis of the market based on the molecular type. This includes small molecule and large molecule (LC-MS studies, immunoassays, and others).

Test Type Insights:

• ADME
  • In-Vivo
  • In-Vitro
• PK
• PD
• Bioavailability
• Bioequivalence
• Others

A detailed breakup and analysis of the market based on the test type have also been provided in the report. This includes ADME (in-Vivo and in-Vitro), PK, PD, bioavailability, bioequivalence, and others.

Workflow Insights:

• Sample Preparation
  • Protein Precipitation
  • Liquid-Liquid Extraction
  • Solid Phase Extraction
• Sample Analysis
  • Hyphenated Technique
  • Chromatographic Technique
  • Electrophoresis
  • Ligand Binding Assay
  • Mass Spectrometry
  • Nuclear Magnetic Resonance
• Others

A detailed breakup and analysis of the market based on the workflow have also been provided in the report. This includes sample preparation (protein precipitation, liquid-liquid extraction, and solid phase extraction), sample analysis (hyphenated technique, chromatographic technique, electrophoresis, ligand binding assay, mass spectrometry, and nuclear magnetic resonance), and others.

Regional Insights:

• North India
• South India
• East India
• West India

The report has also provided a comprehensive analysis of all the major regional markets, which include North India, South India, East India, and West India.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

India Bioanalytical Testing Service Market News:

• In December 2024, Indian drugmaker Anthem Biosciences filed for a $397 million IPO, highlighting its expertise in bioanalytical testing services, including early-stage drug discovery and efficacy testing. The Bengaluru-based company also develops active pharmaceutical ingredients (APIs), dietary supplements, and probiotics, reinforcing India's growing contract research and bioanalytical testing market.
• In January 2023, Eurofins Scientific announced the expansion of its presence in the Indian pharmaceutical market with a new state-of-the-art campus in Genome Valley, Hyderabad. The acquisition included a facility with capabilities in synthetic organic chemistry, analytical R&D, bioanalytical services, in-vivo pharmacology, safety toxicology, and formulation R&D.

India Bioanalytical Testing Service Market Report Coverage:

Key Questions Answered in This Report:

• How has the India bioanalytical testing service market performed so far and how will it perform in the coming years?
• What is the breakup of the India bioanalytical testing service market on the basis of molecular type?
• What is the breakup of the India bioanalytical testing service market on the basis of test type?
• What is the breakup of the India bioanalytical testing service market on the basis of workflow?
• What is the breakup of the India bioanalytical testing service market on the basis of region?
• What are the various stages in the value chain of the India bioanalytical testing service market? 
• What are the key driving factors and challenges in the India bioanalytical testing services?
• What is the structure of the India bioanalytical testing service market and who are the key players?
• What is the degree of competition in the India bioanalytical testing service market? 

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the India bioanalytical testing service market from 2019-2033.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the India bioanalytical testing service market.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the India bioanalytical testing services industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.